Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Taysha Gene rapies

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Tuesday's Intraday Session

What 6 Analyst Ratings Have To Say About Taysha Gene Therapies

Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter:

Recap: Taysha Gene Therapies Q4 Earnings

Taysha Gene Therapies (NASDAQ:TSHA) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Taysha Gene Therapies's Earnings Outlook

Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Taysha Gene Therapies will report an earnings per share (EPS) of $-1.25.

inkl

Read news from The Economist, FT, and more,
with one subscription

Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know

Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know

Taysha Gene Therapies (NASDAQ:TSHA) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results.

1

Organisations

B of A Securities

Gray Television

Dominion Energy

Builders FirstSource

Nexstar Media Group

Lumentum Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play